Myomo Inc. unveils presentation highlighting wearable robotics for upper limb paralysis and Medicare reimbursement expansion
I'm PortAI, I can summarize articles.
Myomo Inc. has released an investor presentation highlighting its strategic position in the wearable medical robotics market, focusing on the MyoPro myoelectric orthosis for upper limb paralysis. The presentation covers expanded Medicare reimbursement, approvals in Germany and Australia, and new distribution channels. Updated reimbursement rates under HCPCS codes L8701 and L8702 are set for January 2025. The company sees a substantial market opportunity due to an expanded addressable population and global reimbursement efforts.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments